Pushkal Garg, CMO & EVP Development & Med Affairs at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 9,766 shares at $300.00 ($2.9M) on 2025-03-24, disclosed to the SEC on 2025-03-25.
Scheduled sale ($2.9M) by CMO & EVP Development & Med Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $285.00 | 4,321 | $1.2M | 43.0% |
| 2 | $300.00 | 5,445 | $1.6M | 57.0% |
| Total | $293.36 avg | 9,766 | $2.9M | 100% |
| Filing → |
| ALNY | SELL | 2026-03-02 | $1.5M | — | Filing → |
| ALNY | SELL | 2026-02-17 | $695K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |